ODI Pharma AB
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ODI.ST research report →
Companywww.odipharma.com
ODI Pharma AB (publ), a pharmaceutical company, produces and distributes pharmaceutical cannabis and cosmetics products in Europe. The company offers cannabidiol-infused facial cream, facial mask, and body balm under the Kandol. brand name through kandol.
- CEO
- Jan-Mark Edewaard
- IPO
- 2020
- Employees
- 1
- HQ
- Stockholm, SE
Price Chart
Valuation
- Market Cap
- $71.49M
- P/E
- -96.06
- P/S
- 3.60
- P/B
- 36.95
- EV/EBITDA
- -760.95
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 21.30%
- Op Margin
- -1.03%
- Net Margin
- -3.75%
- ROE
- -76.62%
- ROIC
- -10.53%
Growth & Income
- Revenue
- $3.11M · -86.04%
- Net Income
- $-5,878,893 · -934.91%
- EPS
- $-0.32 · -757.91%
- Op Income
- $-5,235,128
- FCF YoY
- -40.52%
Performance & Tape
- 52W High
- $5.45
- 52W Low
- $1.00
- 50D MA
- $3.88
- 200D MA
- $2.70
- Beta
- 0.83
- Avg Volume
- 11.94K
Get TickerSpark's AI analysis on ODI.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ODI.ST Coverage
We haven't published any research on ODI.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ODI.ST Report →